Similar articles

• [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].

  Battke K, Buchwalsky R, Barmeyer J, Hoffmann G, Reindell H. Battke K, et al. Fortschr Med. 1978 Jul 20;96(26-27):1381-6. Fortschr Med. 1978. PMID: 669532 Clinical Trial. German. No abstract available.
• [7-year therapy of chronic obliterating vascular diseases].

  König FK. König FK. Med Welt. 1977 Feb 18;28(7):350-3. Med Welt. 1977. PMID: 321912 Clinical Trial. German. No abstract available.
• [Chronic arterial insufficiency of lower limbs: treatment by bencyclan (fludilat) (author's transl)].

  Krähenbühl B. Krähenbühl B. Schweiz Rundsch Med Prax. 1975 May 20;64(20):632-4. Schweiz Rundsch Med Prax. 1975. PMID: 1099573 Clinical Trial. French. No abstract available.
• [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].

  Trübestein G, Trübestein R, Ludwig M. Trübestein G, et al. Fortschr Med. 1989 Dec 20;107(36):781-4. Fortschr Med. 1989. PMID: 2695437 Clinical Trial. German.
• [Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].

  Jonderko G, Szramek-Urbaniak A, Bednarczyk-Kałuzna M. Jonderko G, et al. Przegl Lek. 1982;39(9):617-20. Przegl Lek. 1982. PMID: 7178532 Polish. No abstract available.